Radziuk J
Diabetes Metab Rev. 1987 Jan;3(1):231-67. doi: 10.1002/dmr.5610030111.
Figure 18 outlines a summary of the results obtained in our laboratory and how these might be interpreted. Following a 100-g oral glucose load, about 25 g is taken up by the liver. About 5 g or 5% of this would be removed on a first-pass basis since only about a fifth of the portal vein glucose is newly absorbed. The remainder of the glucose is disposed of in peripheral tissues. This disposal is enhanced by intestinal insulinotropic factors that stimulate insulin secretion. Lactate is produced peripherally (with the red cells as one of the most important sources) by the gut and, perhaps, by hepatocytes. It is taken up by gluconeogenetic hepatocytes to form glycogen. This pathway appears to account for half to two-thirds of glycogen synthesis, the remainder being by direct uptake of glucose. The gluconeogenetic pathway of glycogen formation may be important in that it clears the obligatory production of lactate from certain tissues. The only difference between intravenous and oral glucose loading is that there is no absorbed glucose in the portal vein when glucose is infused. The glucose concentrations here are, however, almost the same as during oral glucose loading since peripheral clearance of glucose is slower in the absence of insulinotropic intestinal factors. This helps to explain why liver handling of intravenous glucose and glycogen formation are almost identical to the case of oral loading.
图18概述了我们实验室获得的结果以及这些结果可能的解释。口服100克葡萄糖后,肝脏摄取约25克。其中约5克或5%会在首次通过时被清除,因为门静脉葡萄糖中只有约五分之一是新吸收的。其余葡萄糖在外周组织中被处理。肠道促胰岛素因子刺激胰岛素分泌,从而增强这种处理过程。乳酸由肠道或许还有肝细胞在外周产生(红细胞是最重要的来源之一)。它被进行糖异生的肝细胞摄取以形成糖原。这条途径似乎占糖原合成的一半到三分之二,其余部分则通过直接摄取葡萄糖形成。糖原形成的糖异生途径可能很重要,因为它清除了某些组织中必然产生的乳酸。静脉注射葡萄糖和口服葡萄糖负荷之间的唯一区别在于,静脉输注葡萄糖时门静脉中没有吸收的葡萄糖。然而,这里的葡萄糖浓度与口服葡萄糖负荷时几乎相同,因为在没有肠道促胰岛素因子的情况下,外周葡萄糖清除较慢。这有助于解释为什么肝脏对静脉注射葡萄糖的处理和糖原形成与口服负荷的情况几乎相同。